QUINCE THERAPEUTICS INC (QNCX) Institutional Ownership and Insiders Activity

QUINCE THERAPEUTICS INC (QNCX) is widely held by institutional investors, with 25 firms reporting positions valued at approximately $17.30M based on SEC Form 13F filings for the quarter ended June 30, 2026.

Balyasny Asset Management L.P. is the largest disclosed holder, reporting approximately $12.56M in QNCX holdings in its latest filing.

Institutional ownership remains highly concentrated, with Balyasny Asset Management L.P. representing the majority of disclosed value.